In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Copyright © 2025 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback